0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GFP Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-22V8631
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GFP Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global GFP Antibody Market Research Report 2025

Code: QYRE-Auto-22V8631
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

GFP Antibody Market

The global market for GFP Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antibodies are?proteins that protect you when an unwanted substance enters your body.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.
This report aims to provide a comprehensive presentation of the global market for GFP Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GFP Antibody.
The GFP Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GFP Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GFP Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GFP Antibody Market Report

Report Metric Details
Report Name GFP Antibody Market
Segment by Type
  • Polyclonal
  • Monoclonal
Segment by Application
  • Western Blot
  • Immunohistochemistry
  • Immunocytochemistry
  • Immunofluorescence
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Aviva Systems Biology, Santa Cruz Biotechnology, Miltenyi Biotec, Proteintech, Synaptic Systems, NSJ Bioreagents, Medimabs, EXBIO, Bio X Cell, ProSci, United States Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of GFP Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GFP Antibody Market report?

Ans: The main players in the GFP Antibody Market are Thermo Fisher Scientific, Aviva Systems Biology, Santa Cruz Biotechnology, Miltenyi Biotec, Proteintech, Synaptic Systems, NSJ Bioreagents, Medimabs, EXBIO, Bio X Cell, ProSci, United States Biological

What are the Application segmentation covered in the GFP Antibody Market report?

Ans: The Applications covered in the GFP Antibody Market report are Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Others

What are the Type segmentation covered in the GFP Antibody Market report?

Ans: The Types covered in the GFP Antibody Market report are Polyclonal, Monoclonal

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GFP Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global GFP Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Western Blot
1.3.3 Immunohistochemistry
1.3.4 Immunocytochemistry
1.3.5 Immunofluorescence
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GFP Antibody Market Perspective (2020-2031)
2.2 Global GFP Antibody Growth Trends by Region
2.2.1 Global GFP Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 GFP Antibody Historic Market Size by Region (2020-2025)
2.2.3 GFP Antibody Forecasted Market Size by Region (2026-2031)
2.3 GFP Antibody Market Dynamics
2.3.1 GFP Antibody Industry Trends
2.3.2 GFP Antibody Market Drivers
2.3.3 GFP Antibody Market Challenges
2.3.4 GFP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GFP Antibody Players by Revenue
3.1.1 Global Top GFP Antibody Players by Revenue (2020-2025)
3.1.2 Global GFP Antibody Revenue Market Share by Players (2020-2025)
3.2 Global GFP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by GFP Antibody Revenue
3.4 Global GFP Antibody Market Concentration Ratio
3.4.1 Global GFP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GFP Antibody Revenue in 2024
3.5 Global Key Players of GFP Antibody Head office and Area Served
3.6 Global Key Players of GFP Antibody, Product and Application
3.7 Global Key Players of GFP Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GFP Antibody Breakdown Data by Type
4.1 Global GFP Antibody Historic Market Size by Type (2020-2025)
4.2 Global GFP Antibody Forecasted Market Size by Type (2026-2031)
5 GFP Antibody Breakdown Data by Application
5.1 Global GFP Antibody Historic Market Size by Application (2020-2025)
5.2 Global GFP Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America GFP Antibody Market Size (2020-2031)
6.2 North America GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America GFP Antibody Market Size by Country (2020-2025)
6.4 North America GFP Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GFP Antibody Market Size (2020-2031)
7.2 Europe GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe GFP Antibody Market Size by Country (2020-2025)
7.4 Europe GFP Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GFP Antibody Market Size (2020-2031)
8.2 Asia-Pacific GFP Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific GFP Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific GFP Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GFP Antibody Market Size (2020-2031)
9.2 Latin America GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America GFP Antibody Market Size by Country (2020-2025)
9.4 Latin America GFP Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GFP Antibody Market Size (2020-2031)
10.2 Middle East & Africa GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa GFP Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa GFP Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific GFP Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in GFP Antibody Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Aviva Systems Biology
11.2.1 Aviva Systems Biology Company Details
11.2.2 Aviva Systems Biology Business Overview
11.2.3 Aviva Systems Biology GFP Antibody Introduction
11.2.4 Aviva Systems Biology Revenue in GFP Antibody Business (2020-2025)
11.2.5 Aviva Systems Biology Recent Development
11.3 Santa Cruz Biotechnology
11.3.1 Santa Cruz Biotechnology Company Details
11.3.2 Santa Cruz Biotechnology Business Overview
11.3.3 Santa Cruz Biotechnology GFP Antibody Introduction
11.3.4 Santa Cruz Biotechnology Revenue in GFP Antibody Business (2020-2025)
11.3.5 Santa Cruz Biotechnology Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec GFP Antibody Introduction
11.4.4 Miltenyi Biotec Revenue in GFP Antibody Business (2020-2025)
11.4.5 Miltenyi Biotec Recent Development
11.5 Proteintech
11.5.1 Proteintech Company Details
11.5.2 Proteintech Business Overview
11.5.3 Proteintech GFP Antibody Introduction
11.5.4 Proteintech Revenue in GFP Antibody Business (2020-2025)
11.5.5 Proteintech Recent Development
11.6 Synaptic Systems
11.6.1 Synaptic Systems Company Details
11.6.2 Synaptic Systems Business Overview
11.6.3 Synaptic Systems GFP Antibody Introduction
11.6.4 Synaptic Systems Revenue in GFP Antibody Business (2020-2025)
11.6.5 Synaptic Systems Recent Development
11.7 NSJ Bioreagents
11.7.1 NSJ Bioreagents Company Details
11.7.2 NSJ Bioreagents Business Overview
11.7.3 NSJ Bioreagents GFP Antibody Introduction
11.7.4 NSJ Bioreagents Revenue in GFP Antibody Business (2020-2025)
11.7.5 NSJ Bioreagents Recent Development
11.8 Medimabs
11.8.1 Medimabs Company Details
11.8.2 Medimabs Business Overview
11.8.3 Medimabs GFP Antibody Introduction
11.8.4 Medimabs Revenue in GFP Antibody Business (2020-2025)
11.8.5 Medimabs Recent Development
11.9 EXBIO
11.9.1 EXBIO Company Details
11.9.2 EXBIO Business Overview
11.9.3 EXBIO GFP Antibody Introduction
11.9.4 EXBIO Revenue in GFP Antibody Business (2020-2025)
11.9.5 EXBIO Recent Development
11.10 Bio X Cell
11.10.1 Bio X Cell Company Details
11.10.2 Bio X Cell Business Overview
11.10.3 Bio X Cell GFP Antibody Introduction
11.10.4 Bio X Cell Revenue in GFP Antibody Business (2020-2025)
11.10.5 Bio X Cell Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci GFP Antibody Introduction
11.11.4 ProSci Revenue in GFP Antibody Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 United States Biological
11.12.1 United States Biological Company Details
11.12.2 United States Biological Business Overview
11.12.3 United States Biological GFP Antibody Introduction
11.12.4 United States Biological Revenue in GFP Antibody Business (2020-2025)
11.12.5 United States Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global GFP Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polyclonal
 Table 3. Key Players of Monoclonal
 Table 4. Global GFP Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global GFP Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global GFP Antibody Market Share by Region (2020-2025)
 Table 8. Global GFP Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global GFP Antibody Market Share by Region (2026-2031)
 Table 10. GFP Antibody Market Trends
 Table 11. GFP Antibody Market Drivers
 Table 12. GFP Antibody Market Challenges
 Table 13. GFP Antibody Market Restraints
 Table 14. Global GFP Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global GFP Antibody Market Share by Players (2020-2025)
 Table 16. Global Top GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2024)
 Table 17. Ranking of Global Top GFP Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by GFP Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of GFP Antibody, Headquarters and Area Served
 Table 20. Global Key Players of GFP Antibody, Product and Application
 Table 21. Global Key Players of GFP Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global GFP Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global GFP Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global GFP Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global GFP Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global GFP Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global GFP Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global GFP Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global GFP Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific GFP Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific GFP Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Thermo Fisher Scientific Company Details
 Table 47. Thermo Fisher Scientific Business Overview
 Table 48. Thermo Fisher Scientific GFP Antibody Product
 Table 49. Thermo Fisher Scientific Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 50. Thermo Fisher Scientific Recent Development
 Table 51. Aviva Systems Biology Company Details
 Table 52. Aviva Systems Biology Business Overview
 Table 53. Aviva Systems Biology GFP Antibody Product
 Table 54. Aviva Systems Biology Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 55. Aviva Systems Biology Recent Development
 Table 56. Santa Cruz Biotechnology Company Details
 Table 57. Santa Cruz Biotechnology Business Overview
 Table 58. Santa Cruz Biotechnology GFP Antibody Product
 Table 59. Santa Cruz Biotechnology Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 60. Santa Cruz Biotechnology Recent Development
 Table 61. Miltenyi Biotec Company Details
 Table 62. Miltenyi Biotec Business Overview
 Table 63. Miltenyi Biotec GFP Antibody Product
 Table 64. Miltenyi Biotec Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 65. Miltenyi Biotec Recent Development
 Table 66. Proteintech Company Details
 Table 67. Proteintech Business Overview
 Table 68. Proteintech GFP Antibody Product
 Table 69. Proteintech Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 70. Proteintech Recent Development
 Table 71. Synaptic Systems Company Details
 Table 72. Synaptic Systems Business Overview
 Table 73. Synaptic Systems GFP Antibody Product
 Table 74. Synaptic Systems Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 75. Synaptic Systems Recent Development
 Table 76. NSJ Bioreagents Company Details
 Table 77. NSJ Bioreagents Business Overview
 Table 78. NSJ Bioreagents GFP Antibody Product
 Table 79. NSJ Bioreagents Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 80. NSJ Bioreagents Recent Development
 Table 81. Medimabs Company Details
 Table 82. Medimabs Business Overview
 Table 83. Medimabs GFP Antibody Product
 Table 84. Medimabs Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 85. Medimabs Recent Development
 Table 86. EXBIO Company Details
 Table 87. EXBIO Business Overview
 Table 88. EXBIO GFP Antibody Product
 Table 89. EXBIO Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 90. EXBIO Recent Development
 Table 91. Bio X Cell Company Details
 Table 92. Bio X Cell Business Overview
 Table 93. Bio X Cell GFP Antibody Product
 Table 94. Bio X Cell Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 95. Bio X Cell Recent Development
 Table 96. ProSci Company Details
 Table 97. ProSci Business Overview
 Table 98. ProSci GFP Antibody Product
 Table 99. ProSci Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 100. ProSci Recent Development
 Table 101. United States Biological Company Details
 Table 102. United States Biological Business Overview
 Table 103. United States Biological GFP Antibody Product
 Table 104. United States Biological Revenue in GFP Antibody Business (2020-2025) & (US$ Million)
 Table 105. United States Biological Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. GFP Antibody Picture
 Figure 2. Global GFP Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GFP Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Polyclonal Features
 Figure 5. Monoclonal Features
 Figure 6. Global GFP Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global GFP Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Western Blot Case Studies
 Figure 9. Immunohistochemistry Case Studies
 Figure 10. Immunocytochemistry Case Studies
 Figure 11. Immunofluorescence Case Studies
 Figure 12. Others Case Studies
 Figure 13. GFP Antibody Report Years Considered
 Figure 14. Global GFP Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global GFP Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global GFP Antibody Market Share by Region: 2024 VS 2031
 Figure 17. Global GFP Antibody Market Share by Players in 2024
 Figure 18. Global Top GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by GFP Antibody Revenue in 2024
 Figure 20. North America GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America GFP Antibody Market Share by Country (2020-2031)
 Figure 22. United States GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe GFP Antibody Market Share by Country (2020-2031)
 Figure 26. Germany GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific GFP Antibody Market Share by Region (2020-2031)
 Figure 34. China GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America GFP Antibody Market Share by Country (2020-2031)
 Figure 42. Mexico GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa GFP Antibody Market Share by Country (2020-2031)
 Figure 46. Turkey GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 50. Aviva Systems Biology Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 51. Santa Cruz Biotechnology Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 52. Miltenyi Biotec Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 53. Proteintech Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 54. Synaptic Systems Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 55. NSJ Bioreagents Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 56. Medimabs Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 57. EXBIO Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 58. Bio X Cell Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 59. ProSci Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 60. United States Biological Revenue Growth Rate in GFP Antibody Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India